Stephen Moses: Unterschied zwischen den Versionen
Zur Navigation springen
Zur Suche springen
K |
K (REFjournal uses <init> key) |
||
| Zeile 19: | Zeile 19: | ||
1.</ref> Moses (along with [[Robert C. Bailey]]) was responsible for one of the three major African circumcision trials (funded by NIAID and the Canadian Institutes of Health Research)<ref>{{REFjournal | 1.</ref> Moses (along with [[Robert C. Bailey]]) was responsible for one of the three major African circumcision trials (funded by NIAID and the Canadian Institutes of Health Research)<ref>{{REFjournal | ||
|last=Krieger | |last=Krieger | ||
| − | | | + | |init=JN |
|last2=Bailey | |last2=Bailey | ||
| − | | | + | |init2=RC |
|last3=Opeya | |last3=Opeya | ||
| − | | | + | |init3=J |
|etal=yes | |etal=yes | ||
|date=2005-11 | |date=2005-11 | ||
| Zeile 77: | Zeile 77: | ||
* Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.<ref>{{REFjournal | * Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.<ref>{{REFjournal | ||
|last=Smith | |last=Smith | ||
| − | | | + | |init=JS |
|last2=Backes | |last2=Backes | ||
| − | | | + | |init2=DM |
|last3=Hudgens | |last3=Hudgens | ||
| − | | | + | |init3=MG |
|etal=yes | |etal=yes | ||
|date=2010-01 | |date=2010-01 | ||
| Zeile 97: | Zeile 97: | ||
* Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.<ref>{{REFjournal | * Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.<ref>{{REFjournal | ||
|last=Moses | |last=Moses | ||
| − | |first=S | + | |first=Stephen |
| + | |init=S | ||
| + | |author-link=Stephen Moses | ||
|date=2009-10 | |date=2009-10 | ||
|title=Male circumcision: a new approach to reducing HIV transmission | |title=Male circumcision: a new approach to reducing HIV transmission | ||
| Zeile 112: | Zeile 114: | ||
* Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>{{REFjournal | * Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>{{REFjournal | ||
|last=Mehta | |last=Mehta | ||
| − | | | + | |init=SD |
|last2=Gray | |last2=Gray | ||
| − | | | + | |init2=RH |
|last3=Auvert | |last3=Auvert | ||
| − | | | + | |init3=B |
|etal=yes | |etal=yes | ||
|date=2007-07 | |date=2007-07 | ||
| Zeile 133: | Zeile 135: | ||
* Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.<ref>{{REFjournal | * Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.<ref>{{REFjournal | ||
|last=Bailey | |last=Bailey | ||
| − | | | + | |init=RC |
|last2=Moses | |last2=Moses | ||
| − | |first2=S | + | |first2=Stephen |
| + | |init2=S | ||
| + | |author2-link=Stephen Moses | ||
|last3=Parker | |last3=Parker | ||
| − | | | + | |init3=CB |
|etal=yes | |etal=yes | ||
|date=2007-02 | |date=2007-02 | ||
| Zeile 153: | Zeile 157: | ||
* Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.<ref>{{REFjournal | * Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.<ref>{{REFjournal | ||
|last=Nagelkerke | |last=Nagelkerke | ||
| − | | | + | |init=NJ |
|last2=Moses | |last2=Moses | ||
| − | | | + | |init2=S |
| + | |author2-link=Stephen Moses | ||
|last3=de Vlas | |last3=de Vlas | ||
| − | | | + | |init3=SJ |
|last4=Bailey | |last4=Bailey | ||
| − | | | + | |init4=RC |
|date=2007 | |date=2007 | ||
|title=Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa | |title=Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa | ||
| Zeile 174: | Zeile 179: | ||
* Adult male circumcision outcomes: experience in a developing country setting.<ref>{{REFjournal | * Adult male circumcision outcomes: experience in a developing country setting.<ref>{{REFjournal | ||
|last=Krieger | |last=Krieger | ||
| − | | | + | |init=JN |
|last2=Bailey | |last2=Bailey | ||
| − | | | + | |init2=RC |
|last3=Opeya | |last3=Opeya | ||
| − | | | + | |init3=JC |
|etal=yes | |etal=yes | ||
|date=2007 | |date=2007 | ||
Aktuelle Version vom 27. November 2021, 13:06 Uhr
(Dieser Artikel wurde noch nicht aus dem Englischen übersetzt oder enthält noch englische Textpassagen. Bitte beziehe dich vorerst auf die Informationen im englischen Artikel. Klicke dazu in der IntactiWiki-Navigation im Abschnitt "In anderen Sprachen" auf "English".)
|
| Associates With: |
| Gilgal Society Circlist |
| Colleagues & Benefactors: |
| Daniel T. Halperin Edgar J. Schoen Robert C. Bailey Bertran Auvert Maria J. Wawer Brian J. Morris |
Professor, Depatrments of Medical Microbiology, Community Health Sciences and Medicine. Stephen Moses has been a circumcision proponent since at least 1994.[1] Moses (along with Robert C. Bailey) was responsible for one of the three major African circumcision trials (funded by NIAID and the Canadian Institutes of Health Research)[2] which are being used by the World Health Organization (under the guide of UNAIDS) to endorse circumcision as an HIV prevention method.[3]
Inhaltsverzeichnis
Interests
According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/HIV transmission.[4] Moses has been an advocate of circumcision since at least 1994.[5]
RCT in Kenya
Of the three RCTs being used by the WHO to endorse circumcision as HIV prevention, Stephen Moses and Robert C. Bailey headed the RCT that was carried out in Kenya.[6] All three trials were funded by the American National Institutes of Health.[7]
Active projects
- A randomized, controlled trial of male circumcision to reduce HIV incidence in Kisumu, Kenya.[4]
National Institutes of Health. - Scaling up HIV prevention in Karnataka and southern Maharashtra, Phase II.[4]
Bill & Melinda Gates Foundation. - Monitoring and evaluation of the Avahan project in India.[4]
Bill & Melinda Gates Foundation. - Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, India.[4]
Bill & Melinda Gates Foundation. - Mapping key populations for HIV prevention in Sri Lanka.[4]
World Bank.
Recent publications
- Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.[8]
Smith JS, Hudgens MG, Bailey RC, Agot K, Ndinya-Achola JO, Moses S, et al. Int J Cancer 2010; 126: 572-7. - Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.[9]
Moses S. CIHR/CMAJ 2009; 181: E134-5. - Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.[10]
Mehta SD, Gray RH, Auvert B, Moses S , Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, Wawer MJ, Bailey RC. AIDS 2009; 23: 1557-64. - Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.[11]
Bailey RC, Moses S , Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet 2007; 369: 643-56. - Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.[12]
Nagelkerke NJD, Moses S, de Vlas S, Bailey RC. BMC Infect Dis 2007; 7: 16. - Adult male circumcision outcomes: experience in a developing country setting.[13]
Krieger J, Bailey RC, Agot K, Parker C, Ndinya-Achola JO, Moses S, et al. Urol Int 2007; 78: 235-40.
Einzelnachweise
- ↑ Moses S., Plummer FA, Bradley, JE, Ndinya-Achola, JO, Nagelkerke NJ, and Ronald AR. The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis 1994;21:201-10. 1.
- ↑
Krieger JN, Bailey RC, Opeya J, et al. Adult male circumcision: results of a standardized procedure in Kisumu District, Kenya. BJU Int.. November 2005; 96(7): 1109–13. PMID. DOI.
- ↑
World Health Organization (27. März 2007). WHO and UNAIDS announce recommendations from expert consultation on male circumcision for HIV prevention
. Abgerufen 23. Februar 2011. - ↑ a b c d e f Dr. Moses, Stephen. , University of Manitoba. Abgerufen 23. Februar 2011.
- ↑ Moses S., Plummer FA, Bradley, JE, Ndinya-Achola, JO, Nagelkerke NJ, and Ronald AR. The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis 1994;21:201-10.
- ↑ Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643-56. Abstract
- ↑ (2008).
The Use of Male Circumcision to Prevent HIV Infection
, Doctors Opposing Circumcision. Abgerufen 5. März 2011.
Zitat:...funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa.
- ↑ Smith JS, Backes DM, Hudgens MG, et al. Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int. J. Cancer. Januar 2010; 126(2): 572–7. PMID. PMC. DOI.
- ↑ Moses S. Male circumcision: a new approach to reducing HIV transmission. CMAJ. Oktober 2009; 181(8): E134–5. PMID. PMC. DOI.
- ↑ Mehta SD, Gray RH, Auvert B, et al. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS. Juli 2007; 23(12): 1557–64. PMID. PMC. DOI.
- ↑ Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. Februar 2007; 369(9562): 643–56. PMID. DOI.
- ↑ Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect. Dis.. 2007; 7: 16. PMID. PMC. DOI.
- ↑ Krieger JN, Bailey RC, Opeya JC, et al. Adult male circumcision outcomes: experience in a developing country setting. Urol. Int.. 2007; 78(3): 235–40. PMID. DOI.
